Arteriocyte, Inc. Wins $4.99 Million in Grant Money  
5/1/2009 8:12:22 AM

Bookmark and Share

Private Equity Hub -- Arteriocyte, a commercial stage biotechnology company based in Cleveland, Ohio, has recieved $4.99 million from Ohio Third Frontier Commission’s Research Commercialization Program to expand clinical applications for its products. The company has received venture backing from DW Healthcare Partners.